Protocol Ledger

NCT04296396 · Phase III · COMPLETED

Opioid Prescription After Cesarean Trial

Interventional Phase III clinical trial protocol NCT04296396 sponsored by The George Washington University Biostatistics Center in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-09-21 Enrollment: 5,521 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04296396
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)5,521 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04296396
Protocol FieldVerified Registry Value
NCT IdentifierNCT04296396
Consolidated Lead SponsorThe George Washington University Biostatistics Center
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment5,521 participants (ACTUAL)
Registered Start Date2020-09-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI